Lawrence Karsh, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Astellas
    Date added:
    Date updated:
    10/31/2019
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    10/31/2019
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Bristol Myers Squibb
    Date added:
    Date updated:
    10/31/2019
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Janssen
    Date added:
    Date updated:
    10/31/2019
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Dendreon
    Date added:
    Date updated:
    10/31/2019
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Astra-Zeneca
    Date added:
    Date updated:
    10/31/2019
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    QED
    Date added:
    Date updated:
    10/31/2019
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Genomic Health
    Date added:
    Date updated:
    10/31/2019
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    ABBVIE
    Date added:
    Date updated:
    10/31/2019
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    UroGPO
    Date added:
    Date updated:
    10/31/2019

Pages

Return to The Changing Face of Advanced Prostate Cancer 2022 Webcast (2022)